Hasan Mutlu
Impact in
- Oncology top 10%
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Conservation top 2%
- Art Therapy and Mental Health
Papers in ⓘ
- Oncology 40
- Inflammatory Biomarkers in Disease Prognosis 12
- Cancer Treatment and Pharmacology 7
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 5
- HER2/EGFR in Cancer Research 4
-
- Lung Cancer Treatments and Mutations 8
- Lung Cancer Diagnosis and Treatment 6
- Renal cell carcinoma treatment 5
- Co-authors
- Hasan Şenol Çoşkun (27 shared papers)Deniz Tural (11 shared papers)Yasemin Benderli Cihan (8 shared papers)Hakan Bozcuk (8 shared papers)Abdülsamet Erden (9 shared papers)Mükremın Uysal (11 shared papers)Mustafa Özdoğan (9 shared papers)Şeyda Gündüz (6 shared papers)
- Journals
- Therapeutics and Clinical Risk Management (2 papers)Asian Pacific Journal of Cancer Prevention (16 papers)Journal of Oncology Pharmacy Practice (10 papers)Clinical and Experimental Dermatology (1 paper)European Journal of Cancer Prevention (1 paper)
- Partner nations
- TürkiyeGermanyUnited Kingdom
In The Last Decade
Hasan Mutlu
65 papers receiving 702 citations
Peers
Comparison fields: 5 of 100
- Oncology 435
- Conservation 45
- Internal Medicine 31
- Otorhinolaryngology 35
- Cancer Research 116
Countries citing papers authored by Hasan Mutlu
This map shows the geographic impact of Hasan Mutlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasan Mutlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasan Mutlu more than expected).
Fields of papers citing papers by Hasan Mutlu
This network shows the impact of papers produced by Hasan Mutlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasan Mutlu. The network helps show where Hasan Mutlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hasan Mutlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 59 | |
| 2 | 2008 | 56 | |
| 3 | 2016 | 54 | |
| 4 | 2012 | 44 | |
| 5 | 2014 | 40 | |
| 6 | 2014 | 31 | |
| 7 | 2014 | 31 | |
| 8 | 2011 | 30 | |
| 9 | 2015 | 29 | |
| 10 | 2013 | 28 | |
| 11 | 2014 | 25 | |
| 12 | 2015 | 22 | |
| 13 | 2014 | 22 | |
| 14 | 2016 | 17 | |
| 15 | 2015 | 16 | |
| 16 | 2014 | 15 | |
| 17 | 2012 | 14 | |
| 18 | 2015 | 13 | |
| 19 | 2013 | 12 | |
| 20 | 2013 | 10 |
About Hasan Mutlu
Hasan Mutlu is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery and Genetics, having authored 69 papers that have together received 726 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (12 papers), Lung Cancer Treatments and Mutations (8 papers), Cancer Treatment and Pharmacology (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Diagnosis and Treatment (6 papers), Renal cell carcinoma treatment (5 papers), Lung Cancer Research Studies (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (435 citations), Conservation (45 citations), Internal Medicine (31 citations), Otorhinolaryngology (35 citations) and Cancer Research (116 citations). Hasan Mutlu has collaborated with scholars based in Türkiye, Germany and United Kingdom. Frequent co-authors include Hasan Şenol Çoşkun, Deniz Tural, Yasemin Benderli Cihan, Hakan Bozcuk, Abdülsamet Erden, Mükremın Uysal, Mustafa Özdoğan, Şeyda Gündüz, Ertan Yılmaz and Ali Akman. Their work appears in journals such as Therapeutics and Clinical Risk Management, Asian Pacific Journal of Cancer Prevention, Journal of Oncology Pharmacy Practice, Clinical and Experimental Dermatology and European Journal of Cancer Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.